Mandate

Vinge advises Odevo in connection with the acquisition of OBOS’ 40% minority stake in SBC and OBOS subsequent investment in Odevo

April 13, 2022 M&A

Vinge advises Odevo in connection with the acquisition of OBOS minority stake of approx. 40 percent in SBC Intressenter HoldCo AB ("SBC") and OBOS’ subsequent investment in Odevo.

OBOS has been a minority investor in SBC since 2019. Through the divestment of its shares in SBC to Odevo, SBC becomes wholly owned by Odevo. Odevo was launched in February and is a new international player that challenges the traditional industry for property and housing management. The foundation for the group was created in 2019 through the formation of Nabo and the acquisition of SBC, and since then the group has grown into a leading international player. The companies within Odevo offer services to residents and property owners supported by Odevo’s own developed platform. The Odevo Group consists of a total of approximately 1,300 employees and has a turnover of just over SEK 1.5 billion.

Vinge’s team consisted of among others Jonas Bergstöm, Joacim Rydergård and Clara Sohlberg.

 

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026